NCT02760641

Brief Summary

The purpose of this study is to determine the effects of change in diet quality (carbohydrate restriction versus fat restriction) on body composition, fat distribution, cardiometabolic risk factors, physical function, and quality of life in aging adults with obesity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for not_applicable obesity

Timeline
Completed

Started Jan 2015

Typical duration for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2015

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

April 28, 2016

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 3, 2016

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2017

Completed
Last Updated

August 21, 2017

Status Verified

October 1, 2016

Enrollment Period

2.5 years

First QC Date

April 28, 2016

Last Update Submit

August 16, 2017

Conditions

Keywords

obesitylow carbohydrate dietmetabolismbody compositionvisceral fatolder adultsinsulin sensitivity

Outcome Measures

Primary Outcomes (7)

  • Changes in total fat mass as measured by dual-energy X-ray absorptiometry (DXA)

    8 weeks after baseline

  • Changes in visceral adipose tissue as measured by magnetic resonance imaging (MRI)

    8 weeks after baseline

  • Changes in total lean mass as measured by DXA

    8 weeks after baseline

  • Changes in subcutaneous abdominal adipose tissue as measured by MRI

    8 weeks after baseline

  • Changes in thigh intermuscular adipose tissue as measured by MRI

    8 weeks after baseline

  • Changes in thigh skeletal muscle volume as measured by MRI

    8 weeks after baseline

  • Changes in thigh subcutaneous adipose tissue as measured by MRI

    8 weeks after baseline

Secondary Outcomes (17)

  • Changes in pro-inflammatory markers, Interleukin (IL)-6

    8 weeks after baseline

  • Changes in pro-inflammatory marker, hsCRP

    8 weeks after baseline

  • Changes in pro-inflammatory marker, Tumor Necrosis Factor (TNF)-α

    8 weeks after baseline

  • Changes in metabolic hormone adiponectin

    8 weeks after baseline

  • Changes in metabolic hormone leptin

    8 weeks after baseline

  • +12 more secondary outcomes

Study Arms (2)

Egg-based diet (EBD)

EXPERIMENTAL

This arm will provide ≤25% energy from CHO, 25% energy from protein, and ≥50% energy from fat. EBD participants will be asked to consume ≥2 eggs per day along with other protein sources including meat, fish, pork, and poultry. Carbohydrate (CHO) sources will be primarily derived from leafy greens and non-starchy vegetables and CHO intake will be equally distributed across meals throughout the day.

Other: Egg-based diet (EBD)

Carbohydrate-based diet (CBD)

PLACEBO COMPARATOR

The CBD group will be asked to avoid whole egg consumption when possible during the 8 week intervention period. They will be counseled to consume a low fat diet with 55:25:20 %energy from CHO:protein:fat. This diet will place an emphasis on consuming lean meats, low fat dairy, whole grains, legumes, fruits and vegetables.

Other: Carbohydrate-based diet (CBD)

Interventions

Participants will be asked to consume a carbohydrate-restricted diet including whole eggs for 8 weeks. Eggs will be provided.

Egg-based diet (EBD)

Participants will be asked to consume a low fat, carbohydrate-based diet for 8 weeks. Breakfast food items will be provided.

Carbohydrate-based diet (CBD)

Eligibility Criteria

Age60 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • between 60-75 years of age,
  • have a BMI ranging from 30-40 kg/m2,
  • sedentary (\<2h/wk of intentional exercise, and agree to maintain their level of activity throughout the study).

You may not qualify if:

  • those with uncontrolled diabetes,
  • unwilling to eat the prescribed diets,
  • recent weight change (+/- 10 lbs. in previous year),
  • history of eating disorder,
  • difficulty chewing and swallowing solid food,
  • digestive diseases,
  • cognitive impairment,
  • uncontrolled blood pressure (systolic blood pressure \> 159 or diastolic blood pressure \>95 mm Hg),
  • history of non-skin cancer in the last 5 years,
  • cardiovascular disease event; severe pulmonary disease; renal failure; major liver dysfunction,
  • current/recent smoker,
  • use of estrogen or testosterone replacement therapy,
  • current use of oral corticosteroids (\>5 d/mth),
  • using medications for treatment of psychosis or manic-depressive illness, and
  • dependence on others for food procurement or preparation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Alabama at Birmingham

Birmingham, Alabama, 35223, United States

Location

Related Publications (2)

  • Hoover SE, Il'yasova D, Fontaine KR, Spasojevic I, Gower BA, Goss AM. A Pilot Study of Associations Between Visceral Fat, IL-6, and Urinary F2-Isoprostanes in Older Adults Exposed to a Diet Intervention. Curr Dev Nutr. 2021 May 21;5(6):nzab082. doi: 10.1093/cdn/nzab082. eCollection 2021 Jun.

  • Goss AM, Gower B, Soleymani T, Stewart M, Pendergrass M, Lockhart M, Krantz O, Dowla S, Bush N, Garr Barry V, Fontaine KR. Effects of weight loss during a very low carbohydrate diet on specific adipose tissue depots and insulin sensitivity in older adults with obesity: a randomized clinical trial. Nutr Metab (Lond). 2020 Aug 12;17:64. doi: 10.1186/s12986-020-00481-9. eCollection 2020.

MeSH Terms

Conditions

ObesityInsulin Resistance

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsHyperinsulinismGlucose Metabolism DisordersMetabolic Diseases

Study Officials

  • Kevin M Fontaine, PhD

    University of Alabama at Birmingham

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigators

Study Record Dates

First Submitted

April 28, 2016

First Posted

May 3, 2016

Study Start

January 1, 2015

Primary Completion

July 1, 2017

Study Completion

July 1, 2017

Last Updated

August 21, 2017

Record last verified: 2016-10

Data Sharing

IPD Sharing
Will not share

Locations